Company Raising Seed Round of Financing
Seeking to exploit growing market niche using data from innovative human drugs to efficiently bring better quality healthcare to the veterinary market
SAN DIEGO, January 14, 2018 — Poïesis Therapeutics, Inc., a biotechnology start-up in the pet health industry, announced today that President and Chief Executive Officer Jessica A. Dugan, DVM, MBA will present at Biotech Showcase ™ 2018, to be held January 8–10 at the Hilton San Francisco Union Square during the most important week in healthcare.
Dr. Dugan will present at the Biotech Showcase™ as follows:
Date: Monday, January 8, 2018,
Time: 9:45 AM (PST)
Room: Franciscan Room – D (Ballroom Level)
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA
Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that Poïesis Therapeutics will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”
“While raising our Seed Round, I am excited to present the market opportunity in pet health to the Biotech Showcase audience,” said Dr. Dugan. “With the $14B US and EU pet medications sector having a projected 5-year CAGR of 6% and with the large animal health pharma companies looking to expand their pet medicine offerings, Poïesis is well positioned within this new and largely untapped biotech space to exploit the growing demand in the pet health market niche by translating human drugs for use in companion animals.”
To address this need, Poïesis is targeting products with annual sales potential of >$100M while projecting that the company’s annual revenues will reach $20M in 2020 and exceed $40M by 2023. Poïesis currently anticipates developing products focused on the treatment of multiple diseases with unmet veterinary needs, including kidney disease, inflammation (cardiovascular & renal), cancer, fungal disease and ophthalmic indications.
ABOUT BIOTECH SHOWCASE™
Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference. Follow Biotech Showcase on Twitter: @EBDGroup and @DemyColton – #BiotechShowcase
ABOUT POÏESIS THERAPEUTICS
Poïesis Therapeutics Inc. is a pet health biotechnology start-up focused on in-licensing clinical stage human therapeutics and developing them for dogs, cats and horses. For more information please visit: www.poiesistherapeutics.com
Jessica A. Dugan, DVM, MBA
President & CEO
Poïesis Therapeutics, Inc.